Webinar

ENETS-NANETS-Webinar:
Highlights of PRRT and drug development abstracts

Keywords:

Systemic therapy, Clinical trials, GEP NETs, PPGL - pheochromocytomas/paragangliomas, Angiogenesis inhibitors, Radioligand therapy

Downloads:

Advanced

Agenda:

PART 1: Nuclear medicine / PRRT abstracts

Opening - Rocío GARCIA CARBONERO

Current trials (20 mins)

NETTER 2 trial (10 mins) – Francesa SPADA
Phase 2 Trial of Lu-177-DOTATATE in Metastatic or Inoperable Pheochromocytoma/Paraganglioma: Interim Analysis Results (5 mins) - Alejandro GARCIA ALVAREZ
Neoadjuvant PRRT in pNET (NeoLuPaNET) (5 mins) - Alejandro GARCIA ALVAREZ

Discussion (20 mins)
Panel: Eric BAUDIN, Jennifer CHAN, Rocío GARCIA CARBONERO, Daniel HALPERIN, Frank LIN, Emil LOU, Erik MITTRA, Stefano PARTELLI + presenters

Closing - Rocío GARCIA CARBONERO

BREAK (5 minutes)


PART 2: Multikinase Inhibitors / Drug development

Introduction - Emil LOU

Current trials (20 mins) - Shagufta SHAHEEN

  • CABINET trial
  • NATALIE in Pheo/para
  • (Combination MKI trials) Everolimus + Lenvatinib (ENETS) and CABATEN trial

Discussion (20 mins)
Panel: Eric BAUDIN, Jennifer CHAN, Rocio GARCIA CARBONERO,  Camilo JIMENEZ, Emil LOU+ presenter

Closing - Emil LOU

Tonight's Moderators:

Tonight's Speakers: